IL17A and neoplasm: Oncogenic-driven NSCLC models have predominantly shown a pro-tumorigenic role of IL17A responses (9, 10), whereas IL17A regulation in a loss of tumor suppressor NSCLC model has been associated with an anti-tumorigenic function (11).